¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-17
±³À°ÀÏÀÚ : 2019-10-17
±³À°Àå¼Ò : °Ç±¹´ëÇб³ »õõ³â°ü ¿ì°î±¹Á¦È¸ÀÇÀå  
±³À°ÁÖÁ¦ : 2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѹ̻ý¹°ÇÐȸ
´ã´çÀÚ : ÃÖ¼¼ÀÎ
¿¬¶ôó : 02-887-3062  
À̸ÞÀÏ : ksm@ksmkorea.org      
±³À°Á¾·ù : ¹Ì»ý¹°ÇР     
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í »çÀüµî·Ï  * ÇÐȸȸ¿ø ±³¼ö/ÀÏ¹Ý – 100,000¿ø Çлý – 60,000¿ø  * ÇÐȸºñȸ¿ø ±³¼ö/ÀÏ¹Ý – 150,000¿ø Çлý – 80,000¿ø   ÇöÀåµî·Ï  * ÇÐȸȸ¿ø ±³¼ö/ÀÏ¹Ý – 150,000¿ø Çлý – 80,000¿ø  * ÇÐȸºñȸ¿ø ±³¼ö/ÀÏ¹Ý – 200,000¿ø Çлý – 90,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 09:30~10:00 ¿¬±¸À±¸®  Basil D¡¯souza(Council of Asian Science Editors) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 10:00~10:30 ±¹³» ¹Ì»ý¹°ÇÐ ±³À°ÇöȲ  À±ÁÖõ(ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 10:30~11:00 ±¹¿Ü ¹Ì»ý¹°ÇÐ ±³À°ÇöȲ  À¯½Â¹Î(À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 11:00~11:30 ¹Ì»ý¹°Çб³À°ÀÇ ¹Ì·¡  ÀÌÀ¯Ã¶ ¿Ü(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 11:45~12:05 Æ¯°­  ÃÖ¸í½Ä(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 12:05~12:35 Innovative idea for development of noble drug, VSF and diagnostic kits in ImmuneMed.  ±èÀ±¿ø(À̹ø޵å) 
Åä·Ð 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 13:30~14:00 Poster Discussion  ½Å¼ºÀç,½Å¹Î°æ(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ, °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 14:00~14:30 Three-year follow-up study on the antibody responses in Korean MERS patients  Á¶³²Çõ(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 14:30~15:00 Recent trends in HCV research  ½ÅÀÇö(Ä«À̽ºÆ®) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 15:00~15:30 Microneedle Vaccines: Novel Strategies to Counter emerging and re-emerging Infectious Diseases  ÀÌÀç¸é(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 15:30~16:00 Influenza virus infections from neglected hosts  ¼Û´ë¼·(°í·Á´ëÇб³ ¾àÇдëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 16:15~16:45 Mechanism of mycobacterial persister formation: new drug-targets for tuberculosis  ¾îÇüÁø(Keck School of Medicine of USC) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 16:45~17:15 Mechanisms and Consequences of Macrophage Cell Death in TB.  Hardy Kornfeld(University of Massachusetts Medical School) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 17:15~17:45 Understanding microbial response to antibiotics through chemical biology  ÀÌ¿ø½Ä(¼º±Õ°ü´ë ¾àÇдëÇÐ) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ The 63rd Annual Congress of the Korean Orthopaedic Association 2019 : 2019-10-17
´ÙÀ½±Û Á¦2ȸ À»Áö´ëÇб³ À»Áöº´¿ø ºñ´¢ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2019-10-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
272 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-17 0 449 2018-07-28
271 °æ±â Á¦ 1ȸ ¾ÆÁִ뺴¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-16 0 2,165 2018-07-28
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 607 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 951 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 851 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 692 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,446 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,231 2018-07-28
264 ¼­¿ï ¼­¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-09-15 0 672 2018-07-28
263 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦2ȸ ÇÏÁö°ñÀý ½ÉÆ÷Áö¾ö : 2018-09-15 0 646 2018-07-28
262 Àü³² ¸ñÆ÷½ÃÀÇ»çȸ Çмú´ëȸ(°æµ¿¸Æ¼Õ»ó,°áÇÙ) : 2018-09-15 0 2,721 2018-07-28
261 ¼­¿ï °í·Á´ëÇб³ ½Å°æ°úÇб³½Ç ½ÉÆ÷Áö¿ò : 2018-09-15 0 1,978 2018-07-28
260 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÄÚºí·¹ÀÌÅ͸¦ ÀÌ¿ëÇÑ ´Ù¾çÇÑ ºñ°ú ¼ö¼úµé : 2018-09-15 0 773 2018-07-28
259 °æ±â Á¦6ȸ ÇѸ²´ëÇб³¼º½Éº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ½ÉÆ÷Áö¿ò : 2018-09-15 0 909 2018-07-28
258 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-14 0 655 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷